TC BioPharm News

TC BioPharm | 8-K: Current report

Apr 4 08:45 ET

TC BioPharm | 10-K: Annual report

Apr 1 17:16 ET

TC BioPharm | 8-K: Current report

Mar 19 08:01 ET

TC BioPharm | 8-K: Current report

Mar 18 08:04 ET

TC BioPharm | 8-K: Current report

Mar 12 07:32 ET

TC BioPharm | 8-K: Current report

Mar 6 06:33 ET

TC BioPharm | DEF 14A: Definitive information statements

Feb 20 06:08 ET

TC BioPharm | 8-K: Current report

Feb 14 15:08 ET

TC BioPharm | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Feb 14 14:39 ET

TC BioPharm | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Feb 9 15:30 ET

TC BioPharm | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MEDINET Co., Ltd.(0.0%)

Jan 29 09:18 ET

TC BioPharm | 8-K: Current report

Jan 4 00:00 ET

TC BioPharm | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 21, 2023 17:14 ET

TC BioPharm | 424B4: Prospectus

Dec 20, 2023 18:42 ET

TC BioPharm | EFFECT: Others

Dec 19, 2023 00:15 ET

TC BioPharm | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Dec 14, 2023 17:20 ET

TC BioPharm | CORRESP: CORRESP

Dec 14, 2023 00:00 ET

TC BioPharm | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 13, 2023 09:05 ET

TC BioPharm | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)

Dec 12, 2023 21:34 ET

TC BioPharm | 424B3: Prospectus

Nov 8, 2023 16:05 ET